Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Dongmun Ha"'
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Predicting pharmacy service fees is crucial to sustain the health insurance budget and maintain pharmacy management. However, there is no evidence on how to predict pharmacy service fees at the population level. This study compare
Externí odkaz:
https://doaj.org/article/da521540778d4bd59f709976d3aa8c68
Autor:
Sang Jae Lee, Dongmun Ha
Publikováno v:
Yakhak Hoeji. 64:65-76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2780a867a6853da62c1e5005037a454b
https://doi.org/10.17480/psk.2020.64.1.65
https://doi.org/10.17480/psk.2020.64.1.65
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 57:489-499
Background and objectives Statin/ezetimibe fixed-dose combination is often used as statin monotherapy; however, no study has analyzed its adverse effect (AE) signals. We comparatively analyzed the AE status of statin and statin/ezetimibe fixed-dose c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5b0bd3ded2a7aa4fad898d8d100b59
https://doi.org/10.5414/cp203374
https://doi.org/10.5414/cp203374
Publikováno v:
Yakhak Hoeji. 63:173-183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12b2075ebde9fa3673de60ac9a981549
https://doi.org/10.17480/psk.2019.63.3.173
https://doi.org/10.17480/psk.2019.63.3.173
Publikováno v:
Journal of Evaluation in Clinical Practice. 23:755-761
Rationale, aims, and objectives Although nonpreference-based disease-specific measures are widely used in clinical studies, they cannot generate utilities for economic evaluation. A solution to this problem is to estimate utilities from disease-speci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0236a08cbc8f4924282e5e6573b646cd
https://doi.org/10.1111/jep.12711
https://doi.org/10.1111/jep.12711
Publikováno v:
Clinical rheumatology. 39(2)
There are no pharmacovigilance studies on adverse event (AE) data for tumour necrosis factor alpha (TNFα) inhibitors in South Korea. We analysed AEs induced by adalimumab, infliximab, and etanercept METHODS: We used data from the Korea Institute of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282522325ef90d66f1821ea3841a0ab9
https://pubmed.ncbi.nlm.nih.gov/31673980
https://pubmed.ncbi.nlm.nih.gov/31673980
Autor:
Lee, Sang-Won, Park, So-Hee, Inmyung Song, Yunha Noh, Hyekyung Park, Dongmun Ha, Shin, Ju-Young
Supplemental Material, 838468_Appendix for Notable Differences in Drug Lag Between Korea and Japan of New Drugs Between 2009 and 2017 by Sang-Won Lee, So-Hee Park, Inmyung Song, Yunha Noh, Hyekyung Park, Dongmun Ha and Ju-Young Shin in Therapeutic In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5fadd4aa20eb25f7224bd8b01c8908e
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Background: Epidemiological evidence regarding healthcare utilization and medical expenditure of patients with psoriasis in Korea is needed. To analyze the differences in healthcare utilizati
Background: Epidemiological evidence regarding healthcare utilization and medical expenditure of patients with psoriasis in Korea is needed. To analyze the differences in healthcare utilizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac91870a2c419e47f340feab6f88033f
https://pubmed.ncbi.nlm.nih.gov/29901614
https://pubmed.ncbi.nlm.nih.gov/29901614
Publikováno v:
International journal of clinical pharmacology and therapeutics. 56(5)
Objectives Tricyclic antidepressants (TCAs) are prescribed with caution in the elderly due to diverse side effects. We analyzed the patterns of TCA use in elderly patients in primary-care and specialty clinics and investigated factors influencing TCA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da437370192fdc42916451b1e223f64
https://pubmed.ncbi.nlm.nih.gov/29578393
https://pubmed.ncbi.nlm.nih.gov/29578393
Autor:
Sang-Won Lee, Ju-Young Shin, Haesun Park, Inmyung Song, Ji Youn Kim, Eui-Kyung Lee, Dongmun Ha
Publikováno v:
International journal of rheumatic diseases. 21(6)
AIM The introduction of biosimilars is expected to reduce the cost of biologic drugs, but the actual cost savings have not yet been quantified in Korea. The aim of this study was to estimate the annual cost savings attributed to the introduction of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6def2ec790b7f1593e27e923af5807d4
https://pubmed.ncbi.nlm.nih.gov/29667324
https://pubmed.ncbi.nlm.nih.gov/29667324